JP2012500258A5 - - Google Patents

Download PDF

Info

Publication number
JP2012500258A5
JP2012500258A5 JP2011523801A JP2011523801A JP2012500258A5 JP 2012500258 A5 JP2012500258 A5 JP 2012500258A5 JP 2011523801 A JP2011523801 A JP 2011523801A JP 2011523801 A JP2011523801 A JP 2011523801A JP 2012500258 A5 JP2012500258 A5 JP 2012500258A5
Authority
JP
Japan
Prior art keywords
alkyl
enzyme
group
compound
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011523801A
Other languages
English (en)
Japanese (ja)
Other versions
JP5597200B2 (ja
JP2012500258A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/004696 external-priority patent/WO2010021686A1/en
Publication of JP2012500258A publication Critical patent/JP2012500258A/ja
Publication of JP2012500258A5 publication Critical patent/JP2012500258A5/ja
Application granted granted Critical
Publication of JP5597200B2 publication Critical patent/JP5597200B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011523801A 2008-08-18 2009-08-18 ルミネッセンスを生じる化合物およびチトクロムp4503a酵素を検出するための方法 Active JP5597200B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8981808P 2008-08-18 2008-08-18
US61/089,818 2008-08-18
PCT/US2009/004696 WO2010021686A1 (en) 2008-08-18 2009-08-18 Luminogenic compounds and methods to detect cytochrome p450 3a enzymes

Publications (3)

Publication Number Publication Date
JP2012500258A JP2012500258A (ja) 2012-01-05
JP2012500258A5 true JP2012500258A5 (cg-RX-API-DMAC10.html) 2012-10-04
JP5597200B2 JP5597200B2 (ja) 2014-10-01

Family

ID=41227208

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011523801A Active JP5597200B2 (ja) 2008-08-18 2009-08-18 ルミネッセンスを生じる化合物およびチトクロムp4503a酵素を検出するための方法

Country Status (4)

Country Link
US (1) US8288559B2 (cg-RX-API-DMAC10.html)
EP (1) EP2323996B1 (cg-RX-API-DMAC10.html)
JP (1) JP5597200B2 (cg-RX-API-DMAC10.html)
WO (1) WO2010021686A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1546162B1 (en) 2002-09-20 2011-06-22 Promega Corporation Luminescence-based methods and probes for measuring cytochrome p450 activity
EP2778234B1 (en) 2005-05-31 2017-09-27 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
WO2010021686A1 (en) 2008-08-18 2010-02-25 Promega Corporation Luminogenic compounds and methods to detect cytochrome p450 3a enzymes
WO2014159044A1 (en) * 2013-03-12 2014-10-02 Promega Corporation Red-shifted luciferins and methods of using same
US11072812B2 (en) 2013-03-15 2021-07-27 Promega Corporation Substrates for covalent tethering of proteins to functional groups or solid surfaces
US9790537B2 (en) 2014-01-29 2017-10-17 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
US9732373B2 (en) * 2014-09-11 2017-08-15 Promega Corporation Luciferase sequences utilizing infrared-emitting substrates to produce enhanced luminescence
ES2974634T3 (es) 2018-12-21 2024-06-28 Celgene Corp Inhibidores de tienopiridinas de RIPK2
CN111100089A (zh) * 2019-12-30 2020-05-05 四川大学华西医院 一种检测亚硫酸盐的生物发光探针及其制备方法和用途
WO2022050233A1 (ja) * 2020-09-03 2022-03-10 黒金化成株式会社 発光システム及びシトクロムp450の定量方法

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929115A1 (de) 1979-07-18 1981-02-12 Boehringer Mannheim Gmbh Verfahren zur herstellung von luciferin
US4665022A (en) 1984-02-17 1987-05-12 The Regents Of The University Of California Bioluminescent assay reagent and method
JPS6124741A (ja) 1984-07-12 1986-02-03 名取 通弘 関節型伸展トラスビ−ム
DE3537877A1 (de) 1985-10-24 1987-04-30 Geiger Reinhard Luciferin-derivate und immunoassays unter einsatz derartiger luciferin-derivate
DE3700908A1 (de) 1987-01-14 1988-07-28 Geiger Reinhard Aminoluciferine, verfahren zu deren herstellung und deren verwendung bei der bestimmung von enzymaktivitaeten
AU609824B2 (en) 1987-06-15 1991-05-09 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
US5498523A (en) 1988-07-12 1996-03-12 President And Fellows Of Harvard College DNA sequencing with pyrophosphatase
US5114704A (en) 1989-05-30 1992-05-19 Nabisco Brands, Inc. Raw hide having a coating containing an inorganic pyrophosphate
CA2022236A1 (en) 1989-07-31 1991-02-01 Hiroaki Yanagisawa Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders
JP3117994B2 (ja) 1990-05-16 2000-12-18 ベイラー・カレツジ・オブ・メデイシン 永久的ヒト肝細胞の細胞系および肝臓補助装置(lad)におけるその使用
US5374534A (en) 1990-07-19 1994-12-20 Charm Sciences, Inc. Method of preparing D-luciferin derivatives
US5283180A (en) 1990-07-19 1994-02-01 Charm Sciences, Inc. Bioluminescence method for the determination of pesticides
US5283179A (en) 1990-09-10 1994-02-01 Promega Corporation Luciferase assay method
US5840739A (en) 1992-11-16 1998-11-24 University Of Florida Research Foundation, Inc. Thiazoline acid derivatives
EP0675955A1 (en) 1992-12-23 1995-10-11 Iowa State University Research Foundation, Inc. Molecular flashlight
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US5650135A (en) 1994-07-01 1997-07-22 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US6217847B1 (en) 1994-07-01 2001-04-17 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
JP3648763B2 (ja) 1994-08-23 2005-05-18 日本油脂株式会社 ウミホタルルシフェリン誘導体および糖加水分解酵素の定量方法
JPH08224096A (ja) 1995-02-20 1996-09-03 Sapporo Breweries Ltd 微生物検査用培地と該培地を用いた微生物検査方法
AU5259296A (en) 1995-04-07 1996-10-23 Warner-Lambert Company Flavones and coumarins as agents for the treatment of athero sclerosis
US5744320A (en) 1995-06-07 1998-04-28 Promega Corporation Quenching reagents and assays for enzyme-mediated luminescence
WO1997008342A1 (en) 1995-08-30 1997-03-06 Gentest Corporation Cytochrome p450 reporter gene
US5902732A (en) 1995-10-04 1999-05-11 Cytoscan Sciences Llc Drug screening process measuring changes in cell volume
US6291164B1 (en) 1996-11-22 2001-09-18 Invitrogen Corporation Methods for preventing inhibition of nucleic acid synthesis by pyrophosphate
US5876946A (en) 1997-06-03 1999-03-02 Pharmacopeia, Inc. High-throughput assay
US6302685B1 (en) * 1997-09-16 2001-10-16 University Of Medicine And Dentistry Of New Jersey Human lysosomal protein and methods of its use
US6602677B1 (en) 1997-09-19 2003-08-05 Promega Corporation Thermostable luciferases and methods of production
WO1999042606A1 (en) 1998-02-23 1999-08-26 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
US6902918B1 (en) 1998-05-21 2005-06-07 California Institute Of Technology Oxygenase enzymes and screening method
US6312917B1 (en) 1998-12-04 2001-11-06 The University Of North Carolina At Chapel Hill Method of screening candidate compounds for susceptibility to oxidative metabolism
US6143492A (en) 1998-12-14 2000-11-07 Aurora Biosciences Corporation Optical molecular sensors for cytochrome P450 activity
DK1140888T3 (da) 1998-12-14 2003-08-25 Vertex Pharma San Diego Llc Optiske molekylære sensorer for cytochrom P450-aktivitet
US6514687B1 (en) 1998-12-14 2003-02-04 Vertex Pharmaceuticals (San Diego), Llc Optical molecular sensors for cytochrome P450 activity
US6420130B1 (en) 1998-12-14 2002-07-16 Aurora Biosciences Corporation Optical molecular sensors for cytochrome P450 activity
JP2000270894A (ja) 1999-03-23 2000-10-03 Kikkoman Corp D−ルシフェリン−O−β−D−グルクロニド誘導体、その製造方法、その誘導体を有効成分とするβ−グルクロニダーゼの活性測定方法、及び大腸菌の検出方法
JP3618572B2 (ja) 1999-03-24 2005-02-09 キッコーマン株式会社 D−システインの測定法
US7118878B1 (en) 2000-06-09 2006-10-10 Promega Corporation Method for increasing luminescence assay sensitivity
JP2002080476A (ja) 2000-08-31 2002-03-19 Iatron Lab Inc D−ルシフェリン類縁体並びにルシフェラーゼ活性分析用試薬及びatp分析用試薬
US6531297B2 (en) 2000-10-20 2003-03-11 Applera Corporation Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
EP1397678A1 (en) 2001-06-01 2004-03-17 Roche Diagnostics GmbH Luciferin hydrazides
US7268229B2 (en) 2001-11-02 2007-09-11 Promega Corporation Compounds to co-localize luminophores with luminescent proteins
FR2831889B1 (fr) 2001-11-08 2004-01-16 Proteus Procede pour generer l'empreinte catalytique idiosyncrasique d'un echantillon, le traitement de ladite empreinte et les systemes pour leur mise en oeuvre
EP1472238B1 (en) 2002-02-01 2012-07-04 Promega Corporation Bioluminescent protease assay
EP1487261B1 (en) 2002-03-05 2008-08-27 MCW Research Foundation, Inc. Methods and compositions for pharmacological and toxicological evaluation of test agents
AU2003270554A1 (en) 2002-09-09 2004-03-29 Applera Corporation Fluorescent enzyme assay methods and compositions
EP1546162B1 (en) * 2002-09-20 2011-06-22 Promega Corporation Luminescence-based methods and probes for measuring cytochrome p450 activity
WO2004059294A2 (en) 2002-12-23 2004-07-15 Promega Corporation Improved luciferase-based assays
WO2005007663A2 (en) 2003-07-14 2005-01-27 Irm Llc Fluorogenic enzyme substrates and uses thereof
RU2242471C1 (ru) 2003-07-31 2004-12-20 Азад Зияд Оглы Абышев Производные 2-н-1-бензопиран-2-она, проявляющие антикальциевую активность
US6913545B2 (en) * 2003-07-31 2005-07-05 Karsten Manufacturing Corporation Golf club head having a face insert with a visual outline
US20080194522A1 (en) 2004-08-25 2008-08-14 Gong Chen Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B)
EP2778234B1 (en) 2005-05-31 2017-09-27 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
JP4899046B2 (ja) 2005-09-30 2012-03-21 国立大学法人 東京大学 新規ルシフェリン誘導体
CN101573357B (zh) * 2006-10-19 2013-01-23 武田药品工业株式会社 吲哚化合物
WO2010021686A1 (en) 2008-08-18 2010-02-25 Promega Corporation Luminogenic compounds and methods to detect cytochrome p450 3a enzymes

Similar Documents

Publication Publication Date Title
ES2568769T3 (es) Derivados de piperazina y su uso como agentes terapéuticos
ES2732230T3 (es) Compuestos que anulan el punto de control G2 del ciclo celular para una utilización en el tratamiento del cáncer
ES2377406T3 (es) Derivados de la piperazina y su uso como agentes terapéuticos
Wang et al. Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 5. An evolution from indole to azaindoles leading to the discovery of 1-(4-benzoylpiperazin-1-yl)-2-(4, 7-dimethoxy-1H-pyrrolo [2, 3-c] pyridin-3-yl) ethane-1, 2-dione (BMS-488043), a drug candidate that demonstrates antiviral activity in HIV-1-infected subjects
ES2386353T3 (es) Derivados de piridazina y su uso como agentes terapéuticos
ES2359840T3 (es) Derivados de piridina para inhibición de estearoil-coa-desaturasa humana.
ES2552684T3 (es) Nuevos compuestos de imidazolidina como moduladores del receptor de andrógenos
RS61381B1 (sr) Derivat policikličnog piridona protiv gripa i njegov prolek
JP2008545746A5 (cg-RX-API-DMAC10.html)
JP2002523450A5 (cg-RX-API-DMAC10.html)
Pace et al. The monoethyl ester of meconic acid is an active site inhibitor of HCV NS5B RNA-dependent RNA polymerase
HUP0400851A2 (hu) Dihidro-benzo[b][1,4]diazepin-2-on-származékok, mint MGluR2 II antagonisták, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
BRPI0718966B8 (pt) composto, composição farmacêutica, inibidor plk1 e agente antitumoral
CY1111876T1 (el) Νεες πυρρολες με υπολiπiδaiμiκες και υποχοληστερολαιμικες δραστικοτητες, μεθοδος για την παρασκευη αυτων και φαρμακευτικες συνθεσεις που τις περιεχουν και η χρηση αυτων στην ιατρικη
NO20072547L (no) 4-metoksymetyl-pyrrolidin-2-karboksylsyreforbindelser og derivater derav som hepatitt C virusinhibitorer
BR9915475A (pt) Derivados da quinolina-4-carboxamida comoantagonistas dos receptores de nk-3 e nk-2
CN103476411B (zh) 标靶人类胸腺核苷酸激酶诱导恶性肿瘤中的dna修复毒性
JP6327431B2 (ja) がん細胞阻害薬、がん幹細胞検出用プローブ
WO2001053272A1 (en) Human chymase inhibitors
CA3202763A1 (en) Benzene ring compound and use thereof
CA2907490A1 (en) Fluorescent-hap: a diagnostic stain for hbv cores in cells
Combrink et al. Respiratory syncytial virus fusion inhibitors. Part 6: an examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety
Wang et al. The novel benzopyran class of selective cyclooxygenase-2 inhibitors-part I: The first clinical candidate
TW201908299A (zh) 含有胺或(硫)醯胺之lxr調節劑
KR20220004206A (ko) 키네이스 억제제로 유용한 치환된 거대고리화합물